Idioma:

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic – São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement

Chagas, Aline Lopes; Fonseca, Leonardo Gomes Da; Coelho, Fabricio Ferreira; Saud, Lisa Rodrigues Da Cunha; Abdala, Edson; Andraus, Wellington; Fiore, Lucas; Moreira, Airton Mota; Menezes, Marcos Roberto; Carnevale, Francisco César; Tani, Claudia Megumi; Alencar, Regiane S. S. M.; D’albuquerque, Luiz Augusto Carneiro; Herman, Paulo; Carrilho, Flair José

Clinics; v. 75 (2020); e2192

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo 2020-08-16

Acesso online

Enviar para

Título:
Management of Hepatocellular Carcinoma during the COVID-19 Pandemic – São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement
Autor: Chagas, Aline Lopes; Fonseca, Leonardo Gomes Da; Coelho, Fabricio Ferreira; Saud, Lisa Rodrigues Da Cunha; Abdala, Edson; Andraus, Wellington; Fiore, Lucas; Moreira, Airton Mota; Menezes, Marcos Roberto; Carnevale, Francisco César; Tani, Claudia Megumi; Alencar, Regiane S. S. M.; D’albuquerque, Luiz Augusto Carneiro; Herman, Paulo; Carrilho, Flair José
Assuntos: Hepatocellular Carcinoma; Hepatocellular Carcinoma/Therapy; Covid-19; Clinical Practice Guideline
É parte de: Clinics; v. 75 (2020); e2192
Descrição: More than 18 million people in 188 countries have been diagnosed as having coronavirus disease (COVID-19), and COVID-19 has been responsible for more than 600,000 deaths worldwide. Brazil is now the second most affected country globally. Faced with this scenario, various public health measures and changes in the daily routines of hospitals were implemented to stop the pandemic. Patients with hepatocellular carcinoma (HCC) are at an increased risk for severe COVID-19 as they present with two major diseases: cancer and concomitant chronic liver disease. The COVID-19 pandemic can significantly impact the management of HCC patients from diagnosis to treatment strategies. These patients need special attention and assistance at this time, especially since treatment for tumors cannot be delayed in most cases. The aim of this guideline was to standardize the management of HCC patients during the COVID-19 pandemic. This document was developed, on the basis of the best evidence available, by a multidisciplinary team from Instituto do Caˆncer do Estado de Sa˜o Paulo (ICESP), and Instituto Central of the Hospital das Clı´nicas da Universidade de Sa˜o Paulo (HC-FMUSP), which are members of the Sa˜o Paulo Clı´nicas Liver Cancer Group.
Títulos relacionados: https://www.revistas.usp.br/clinics/article/view/192404/177322
Editor: Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
Data de criação/publicação: 2020-08-16
Formato: Adobe PDF
Idioma: Inglês

Links

Revistas USP

Voltar para lista de resultados

Anterior Resultado 5 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic – São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo 2020-08-16

Buscando em bases de dados remotas. Favor aguardar.